PF-Atlas › Clinical Trials › NCT04375878

OPTION 2: A Trial to Assess the Safety and Efficacy of MS1819 in Enteric Capsules in Patients With Cystic Fibrosis

MS1819 · Phase 2

Registry ID

NCT04375878

Phase

Phase 2

Status

Completed

Drug / intervention

MS1819

Sponsor

Entero Therapeutics

Start

2020-07-20

About this trial

MS1819 is evaluated in NCT04375878, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Entero Therapeutics. Current status: Completed.

View NCT04375878 on ClinicalTrials.gov →

Explore related

All MS1819 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT04375878 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.